Status:
COMPLETED
Calming Alternatives Learned During MRI-Guided Breast Biopsy
Lead Sponsor:
Duke University
Conditions:
Breast Cancer
Breast Pain
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The proposed randomized study evaluates whether a controlled breathing intervention could be efficacious for reducing pain in the MRI-guided breast biopsy setting. Support for this intervention stems ...
Eligibility Criteria
Inclusion
- Women undergoing MRI-guided core needle breast biopsy at the Duke Cancer Institute
- Ability to speak and read in English
- Age ≥ 18 years
- Ability to provide meaningful consent
Exclusion
- Hearing impairment that is documented in the medical record that would limit the use of the guided intervention or music
- Cognitive impairment that is documented in the medical record or results in being unable to provide meaningful consent
- Undergoing IV-administered sedation
Key Trial Info
Start Date :
October 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT03877146
Start Date
October 16 2018
End Date
June 20 2019
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Institute
Durham, North Carolina, United States, 27710